SPDR Series Trust - State Street SPDR S&P Pharmaceuticals ETF
US ˙ ARCA ˙ US78464A7220

SecurityXPH / SPDR Series Trust - State Street SPDR S&P Pharmaceuticals ETF
InstitutionSigma Planning Corp
Latest Disclosed Ownership6,103 shares
Latest Disclosed Value $ 330,122
Sigma Planning Corp reports 2.66% increase in ownership of XPH / SPDR Series Trust - State Street SPDR S&P Pharmaceuticals ETF

On May 4, 2026 - Sigma Planning Corp filed a 13F-HR form disclosing ownership of 6,103 shares of SPDR Series Trust - State Street SPDR S&P Pharmaceuticals ETF (US:XPH) valued at $330,111 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 30, 2026 disclosing 5,945 shares of SPDR Series Trust - State Street SPDR S&P Pharmaceuticals ETF. This represents a change in shares of 2.66% during the quarter. The current value of the position is $343,690 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-04 2026-03-31 13F SPDR SERIES TRUST STATE STREET SPD 78464A722 6,103 158 2.66 330 -0.60 0.0092
2026-01-30 2025-12-31 13F SPDR SERIES TRUST STATE STREET SPD 78464A722 5,945 108 1.85 333 19.00 0.0092
2025-11-10 2025-09-30 13F SPDR SERIES TRUST S&P PHARMAC 78464A722 5,837 36 0.62 280 18.72 0.0080
2025-08-05 2025-06-30 13F SPDR SERIES TRUST S&P PHARMAC 78464A722 5,801 -93 -1.58 235 -8.91 0.0071
2025-05-02 2025-03-31 13F SPDR SER TR S&P PHARMAC 78464A722 5,894 747 14.51 258 16.74 0.0082
2025-02-03 2024-12-31 13F SPDR SER TR S&P PHARMAC 78464A722 5,147 5,147 221 0.0069
2017-04-24 2017-03-31 13F SPDR SERIES TRUST S&P PHARMAC 78464A722 0 -5,961 -100.00 0 -100.00
2017-01-23 2016-12-31 13F SPDR SERIES TRUST S&P PHARMAC 78464A722 5,961 5,961 233 0.0255
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.